Cronos (CRON) Change in Account Payables (2021 - 2026)
Cronos' (CRON) quarterly Change in Account Payables came in at -$1.2 million in Q1 2026, up 26.33% year-on-year from -$954652.8 in Q1 2025, and down 151.65% quarter-over-quarter from $2.3 million in Q4 2025.
Cronos (CRON) Change in Account Payables (2021 - 2026) Analysis & Trends
Cronos' Change in Account Payables history runs 6 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 26.33% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 124.39% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 114.87% from the prior year.
- Change in Account Payables eased to -$1.2 million in Q1 2026 per CRON's latest filing, from $2.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.8 million in Q4 2023 and bottomed at -$5.1 million in Q3 2023.
- The 5-year median for Change in Account Payables is -$178000.0 (2022), against an average of -$540176.5.
- Biggest YoY gain for Change in Account Payables was 973.6% in 2023; the steepest drop was 711.99% in 2023.
- Year by year, Change in Account Payables stood at $764000.0 in 2022, then surged by 792.93% to $6.8 million in 2023, then sank by 75.77% to $1.7 million in 2024, then soared by 41.26% to $2.3 million in 2025, then plunged by 151.65% to -$1.2 million in 2026.
- Per Business Quant, the three latest CRON Change in Account Payables figures stand at -$1.2 million (Q1 2026), $2.3 million (Q4 2025), and -$171000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | -1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.21 Mn |
| Mar 31, 2026 | -1.21 Mn |
| Dec 31, 2025 | 2.34 Mn |
| Dec 31, 2025 | 2.34 Mn |
| Sep 30, 2025 | -171,000.00 |
| Sep 30, 2025 | -171,000.00 |
| Jun 30, 2025 | 581,000.00 |
| Jun 30, 2025 | 581,000.00 |
| Mar 31, 2025 | -1.64 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | -4.62 Mn |
| Sep 30, 2024 | -4.62 Mn |
| Jun 30, 2024 | -1.71 Mn |
| Jun 30, 2024 | -1.71 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | 6.82 Mn |
| Dec 31, 2023 | 6.82 Mn |